`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________________________
`
`MYLAN PHARMACEUTICALS INC.,
`
`Petitioner,
`
`v.
`
`NOVO NORDISK A/S,
`
`Patent Owner.
`____________________________
`
`Case No. IPR2023-00724
`U.S. Patent No. 10,335,462
`____________________________
`
`MOTION FOR PRO HAC VICE ADMISSION
`OF BRYAN D. BEEL
`
`
`
`
`
`
`
`I.
`
`Statement of Precise Relief Requested
`
`Mylan Pharmaceuticals Inc. (“Mylan”) hereby respectfully requests that the
`
`Patent Trial and Appeal Board (the “Board”) admit Bryan D. Beel pro hac vice in
`
`
`
`this proceeding under 37 C.F.R. § 42.10(c).
`
`Patent Owners have stated they will not oppose this motion.
`
`II.
`
`Statement of Facts Showing Good Cause for the Board to Recognize
`Counsel Pro Hac Vice During the Proceeding
`
`Under 37 C.F.R. § 42.10(c), the Board may admit counsel pro hac vice for
`
`good cause, so long as lead counsel is a registered practitioner and subject to any
`
`other conditions the Board requires. Under Section 42.10(c), good cause includes
`
`when “counsel is an experienced litigating attorney and has an established
`
`familiarity with the subject matter at issue in the proceeding.” This motion satisfies
`
`the requirements of Section 42.10(c):
`
`1.
`
`2.
`
`Lead counsel, Brandon M. White, is a registered practitioner.
`
`Dr. Beel is an experienced patent litigator and has an established
`
`familiarity with the subject matter at issue here, as shown in his accompanying
`
`December 18, 2023 Declaration (“Beel Decl.”), attached hereto. That declaration
`
`shows that Dr. Beel has been a litigator for over 16 years. He is a member in good
`
`standing of the Oregon State Bar and is also admitted in the federal courts. Dr. Beel
`
`is also familiar with the subject matter of this case, including U.S. Patent No.
`
`- 1 -
`
`
`
`
`10,335,462 and its prosecution history, the underlying technology, and the prior art
`
`cited by the petitioner in this matter. Beel Decl. ¶¶ 8-9.
`
`3.
`
`In his declaration, Dr. Beel also attests to each of the listed items
`
`required by the Order – Authorizing Motion for Pro Hac Vice Admission – 37 C.F.R.
`
`§ 42.10 in IPR2013-00639. See Beel Decl. ¶¶ 2-13.
`
`III. Conclusion
`
`For the foregoing reasons, Mylan respectfully requests that the Board admit
`
`Bryan D. Beel, pro hac vice in this proceeding.
`
`Dated: December 18, 2023
`
`
`PERKINS COIE LLP
`700 Thirteenth Street, N.W., Suite 800
`Washington, D.C. 20005-3960
`202.654.6200 (phone)
`202.654.6211 (fax)
`
`
`
`Respectfully submitted,
`
`/Brandon M. White/
`Lead Counsel
`Brandon M. White, Reg No. 52,354
`
`
`Attorneys for Petitioner
`
`
`
`
`
`
`
`- 2 -
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served a true and
`correct copy of the foregoing:
`
`
`1. MOTION FOR PRO HAC VICE ADMISSION OF BRYAN D. BEEL, and
`
`2.
`
`DECLARATION OF BRYAN D. BEEL IN SUPPORT OF MOTION FOR
`PRO HAC VICE ADMISSION OF BRYAN D. BEEL
`
`by email to the electronic service addresses for Patent Owner
`
`
`J. Steven Baughman
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP
`steve.baughman@groombridgewu.com
`
`Megan Raymond
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP
`megan.raymond@groombridgewu.com
`
`Novo-Semaglutide-IPR@groombridgewu.com
`
`
`
`Dated: December 18, 2023
`
`
`PERKINS COIE LLP
`700 Thirteenth Street, N.W., Suite 800
`Washington, D.C. 20005-3960
`202.654.6200 (phone)
`202.654.6211 (fax)
`
`
`
`
`/Brandon M. White/
`Lead Counsel
`Brandon M. White, Reg No. 52,354
`
`
`Attorneys for Petitioner
`
`- 3 -
`
`